
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The companys best-in-class product offerings include Arteriocytes market-leading MAGELLAN Autologous Platelet Separator and Istos bone-growth and cell-therapy products including InQu Bone Graft Extender & Substitute; Influx, a natural bone-graft material; and CellPoint, a concentrated bone marrow aspirate system
Platelet rich plasma
Arteriocyte (now isto biologics) operates in the Medical device industry.
Arteriocyte (now isto biologics)'s revenue is 11m - 100m
Arteriocyte (now isto biologics) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.